Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Polar Capital Global Healthcare Trust paints confident outlook as sentiment picks up

(Sharecast News) - London-listed healthcare investor Polar Capital Global Healthcare Trust reported a decline in the value of its portfolio over the fiscal year to 30 September amid a "difficult market backdrop", but said it has seen an improvement in sentiment across the investment trust sector over recent months. Net asset value per share fell by 5.9% over the year, though that still outperformed the company's benchmark index - the MSCI ACWI Healthcare Index total return in sterling with dividends reinvested - which returned -7.8%.

PCGHT's total net assets were valued at £448.1m at the end of the period, down 6.5% from the £479.1m valuation reported a year earlier, with NAV per share falling to 369.51p from 395.05p.

Since the period-end, the company underwent a major reorganisation with shareholders supporting the transition from a fixed-life trust - due for liquidation this year - to an open-ended structure indefinitely.

Despite giving shareholders the option to realise their investments via a tender offer, nearly 80% of shareholders chose to remain invested, with 22.47% of shares repurchased by the company and placed into treasury.

Chair Lisa Arnold said "sentiment appeared to have improved for the healthcare sector" in the early months of the new financial year, "with some outperformance against the wider market".

"Demand for healthcare products remains robust, whilst other long term drivers including industry consolidation, accelerated demand in emerging markets and the adoption of artificial intelligence technologies all support a strong foundation to drive much needed efficiencies and better patient outcomes.

"The board will continue to monitor performance but remains very optimistic about the outlook for the healthcare sector and the opportunities to generate returns for shareholders, especially with the revised structure for which shareholders have given their support."

The stock was up 0.79% at 432.38p by 0958 GMT.

Share this article

Related Sharecast Articles

ConocoPhillips to buy 42% stake in BP Iraq oil fields
(Sharecast News) - BP said on Friday that it has agreed terms for ConocoPhillips to buy a 42% interest in BP Energy Company of Kirkuk (BP ECKL).
GSK shares fall as cough drug development axed
(Sharecast News) - Shares in GSK fell sharply on Friday after the pharma titan announced it was stopping the development of a refractory chronic cough drug after unsuccessful results late-stage clinical trial.
Deutsche Bank downgrades Rotork after ABB takeover
(Sharecast News) - Deutsche Bank downgraded Rotork on Friday to 'hold' from 'buy' and lifted the price target to 503p from 400p after it agreed to be bought by Swiss engineering firm ABB in a £4.1bn deal.
Wise Q1 revenues rise as customer numbers grow
(Sharecast News) - Wise reported an increase in first-quarter revenue on Friday as customer numbers at the money transfer firm rose.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.